US Launches Investigation Into German Drug Pricing Practices
President Trump has put Germany on notice over drug pricing, launching a formal trade probe and warning that America will not subsidize foreign health systems forever. This piece explains the case against Germany’s low drug prices, the economics behind innovation, the Section 301 probe, the U.K. precedent, and why forcing fairness matters for American patients...